© 1969 by Biometrika Trust
On the theory of screening for chronic diseases
State University of New York at Buffalo
National Institutes of Health
It is assumed that a chronic disease progresses from a pre-clinical state to a clinical state. If an individual, having pre-clinical disease, participates in an early detection programme, the disease may be detected in the pre-clinical state. The potential benefit of a screening programme is related to the lead time gained by early diagnosis. A stochastic model is developed for early detection programmes which leads to an estimate of the mean lead time as a function of observable variables. An investigation is also made of a non-progressive disease model in which individuals in a pre-clinical state may not necessarily advance to the clinical state.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
X. Luo and W. Y. Tsai Nonparametric estimation for right-censored length-biased data: a pseudo-partial likelihood approach Biometrika, December 1, 2009; 96(4): 873 - 886. [Abstract] [PDF] |
||||
![]() |
G. Draisma, R. Etzioni, A. Tsodikov, A. Mariotto, E. Wever, R. Gulati, E. Feuer, and H. de Koning Lead Time and Overdiagnosis in Prostate-Specific Antigen Screening: Importance of Methods and Context J Natl Cancer Inst, March 18, 2009; 101(6): 374 - 383. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. Ahern and Y. Shen Cost-Effectiveness Analysis of Mammography and Clinical Breast Examination Strategies: A Comparison with Current Guidelines Cancer Epidemiol. Biomarkers Prev., March 1, 2009; 18(3): 718 - 725. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. W. Duffy, I. D. Nagtegaal, M. Wallis, F. H. Cafferty, N. Houssami, J. Warwick, P. C. Allgood, O. Kearins, N. Tappenden, E. O'Sullivan, et al. Correcting for Lead Time and Length Bias in Estimating the Effect of Screen Detection on Cancer Survival Am. J. Epidemiol., July 1, 2008; 168(1): 98 - 104. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lee and M. Zelen Chapter 11: A Stochastic Model for Predicting the Mortality of Breast Cancer J Natl Cancer Inst Monographs, October 1, 2006; 2006(36): 79 - 86. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Shen and M. Zelen Robust modeling in screening studies: estimation of sensitivity and preclinical sojourn time distribution Biostat., October 1, 2005; 6(4): 604 - 614. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. E. Chapman, D. F. Yankelevitz, C. I. Henschke, and D. Gur Lung Cancer Screening: Simulations of Effects of Imperfect Detection on Temporal Dynamics Radiology, February 1, 2005; 234(2): 582 - 590. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lee, H. Huang, and M. Zelen Early detection of disease and scheduling of screening examinations Statistical Methods in Medical Research, December 1, 2004; 13(6): 443 - 456. [Abstract] [PDF] |
||||
![]() |
L G Hanin and A Y Yakovlev Multivariate distributions of clinical covariates at the time of cancer detection Statistical Methods in Medical Research, December 1, 2004; 13(6): 457 - 489. [Abstract] [PDF] |
||||
![]() |
P. Hu and M. Zelen Planning of randomized early detection trials Statistical Methods in Medical Research, December 1, 2004; 13(6): 491 - 506. [Abstract] [PDF] |
||||
![]() |
R. Varadhan and C. E. Frangakis Revealing and Addressing Length Bias and Heterogeneous Effects in Frequency Case-Crossover Studies Am. J. Epidemiol., March 15, 2004; 159(6): 596 - 602. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Shen and M. Zelen Screening Sensitivity and Sojourn Time From Breast Cancer Early Detection Clinical Trials: Mammograms and Physical Examinations J. Clin. Oncol., August 1, 2001; 19(15): 3490 - 3499. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D Etzioni, R. J Connor, P. C Prorok, and S. G Self Design and analysis of cancer screening trials Statistical Methods in Medical Research, March 1, 1995; 4(1): 3 - 17. [Abstract] [PDF] |
||||
![]() |
C. Stevenson Statistical models for cancer screening Statistical Methods in Medical Research, March 1, 1995; 4(1): 18 - 32. [Abstract] [PDF] |
||||
![]() |
G. van Oortmarssen, R. Boer, and J. Habbema Modelling issues in cancer screening Statistical Methods in Medical Research, March 1, 1995; 4(1): 33 - 54. [Abstract] [PDF] |
||||
![]() |
T. O'Neill, G. Tallis, and P. Leppard A review of the technical features of breast cancer screening illustrated by a specific model using South Australian cancer registry data Statistical Methods in Medical Research, March 1, 1995; 4(1): 55 - 72. [Abstract] [PDF] |
||||
![]() |
C. F. Torres, S. Rebsamen, J. H. Silber, L. N. Sutton, L. T. Bilaniuk, R. A. Zimmerman, J. W. Goldwein, P. C. Phillips, and B. J. Lange Surveillance Scanning of Children with Medulloblastoma N. Engl. J. Med., March 31, 1994; 330(13): 892 - 895. [Abstract] [Full Text] |
||||
![]() |
R. Detels, V. A. Clark, N. L. Valdiviezo, B. R. Visscher, R. M. Malmgren, and J. P. Dudley Factors Associated With a Rapid Course of Multiple Sclerosis Arch Neurol, June 1, 1982; 39(6): 337 - 341. [Abstract] [PDF] |
||||










